Assembly biosciences, inc. (ASMB)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Collaboration revenue

4,081

4,767

4,231

3,080

3,885

-

4,286

3,218

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

3,565

-

2,659

2,359

684

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

23,046

22,617

21,736

18,700

22,704

21,251

19,109

17,840

14,541

10,596

10,929

12,125

10,573

8,622

8,833

7,519

8,118

5,225

4,630

4,667

3,834

2,975

3,671

1,095

2,973

5,158

3,753

3,508

2,609

2,741

4,188

6,161

6,422

17,540

3,667

3,099

970

193

521

General and administrative

8,729

10,834

8,488

4,080

9,517

8,806

7,752

12,544

5,696

4,998

4,180

3,801

4,040

3,245

2,845

2,935

3,158

2,950

2,492

2,486

3,368

3,309

7,383

1,410

1,136

935

1,179

1,300

1,159

1,075

1,182

1,316

1,767

1,347

1,878

3,801

1,696

317

138

Total operating expenses

31,775

-

-

-

32,221

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

30,224

22,780

-

-

26,861

30,384

20,237

-

15,109

15,926

14,614

11,867

11,678

10,454

11,277

8,176

7,122

7,153

7,203

6,284

11,055

2,506

4,110

-

4,933

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-27,694

-28,684

-25,993

-19,700

-28,336

-26,322

-22,575

-27,166

-16,672

-12,279

-12,450

-13,567

-13,929

-11,867

-11,678

-10,454

-11,277

-8,176

-7,122

-7,153

-7,203

-6,284

-11,055

-2,506

-4,110

-6,094

-4,933

-4,808

-3,768

-3,816

-5,370

-7,478

-8,190

-18,887

-5,545

-6,901

-2,666

-510

-659

Other income
Interest and other income, net

1,039

858

983

1,182

1,277

1,068

1,116

453

446

365

241

239

136

225

378

444

490

456

502

211

58

55

35

36

40

-

51

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-

-

-

4

-

-

-82

-127

-23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized loss from marketable securities

-

-

-

-

-

-

-

-

-

-

-99

-340

-137

-

-273

-142

-201

-28

1

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

0

-

-

-

-

Amortization of debt discount and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

253

24

24

580

784

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

30

41

-

686

-

Total other income

1,039

859

983

1,186

1,277

1,300

1,034

326

423

327

142

-101

-0

-296

104

301

288

428

504

211

58

55

35

36

40

-

51

-

-

65

0

0

0

-

-

-

-69

-

-

Loss before income taxes

-26,655

-27,825

-25,010

-18,514

-27,059

-25,022

-21,541

-26,840

-16,249

-

-12,307

-13,668

-

-

-11,574

-10,152

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-

-741

-15

-11

-7

1,139

-6

-34

0

-

-35

-69

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56

45

25

14

8

16

28

28

5

13

0

1

Interest Expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

283

65

44

1,266

684

Net loss

-26,655

-27,084

-24,995

-18,503

-27,052

-26,161

-21,535

-26,806

-16,249

-3,007

-12,272

-13,598

-13,930

-11,546

-11,574

-10,152

-10,988

-7,748

-6,617

-6,942

-7,144

-6,229

-11,020

-2,469

-4,069

-6,047

-4,881

-4,751

-3,723

-3,791

-5,355

-7,470

-8,173

-18,859

-5,801

-6,961

-2,722

-1,776

-2,127

Other comprehensive (loss) income
Unrealized loss recognized in accumulated other comprehensive loss before reclassification, net of tax benefit of $50,664, $31,844, $44,192 and $89,281, respectively

115

4

-18

52

108

8

17

87

-67

352

-51

-31

-61

854

-270

-232

-129

-

252

134

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification adjustment of unrealized loss included in net loss, net of tax expense of $56,139, $37,987, $56,139 and $221,358, respectively

-

-

-

-

-

-

-

-

-

-

61

157

137

-

273

142

201

-

-1

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-26,540

-27,080

-25,013

-18,451

-26,944

-26,153

-21,518

-26,719

-16,316

-3,010

-12,262

-13,472

-13,854

-11,310

-11,571

-10,242

-10,916

-8,181

-6,871

-7,076

-7,144

-

-11,020

-2,469

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic and diluted

-0.76

-0.99

-0.96

-0.72

-1.05

-1.01

-0.87

-1.30

-0.80

-0.11

-0.71

-0.78

-0.81

-0.67

-0.67

-0.59

-0.64

-0.38

-0.38

-0.41

-0.64

-0.63

-1.33

-0.52

-0.92

-2.35

-1.23

-1.20

-0.22

-0.28

-0.41

-0.59

-0.66

-1.72

-0.50

-0.97

-0.38

-3.97

-4.76

Weighted average common shares outstanding, basic and diluted

35,079

27,713

25,912

25,740

25,668

25,554

24,878

20,541

20,231

19,023

17,367

17,342

17,268

17,228

17,225

17,225

17,225

17,308

17,205

17,119

11,176

10,594

8,277

4,704

4,418

-9,464

3,978

3,944

17,055

12,936

12,933

12,627

12,408

12,514

11,616

7,176

7,147

447

447